Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 305.96M | 263.84M | 142.34M | 107.42M | 92.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 305.96M | 263.84M | 142.34M | 107.42M | 92.82M |
| Cost of Revenue | 47.42M | 44.22M | 29.37M | 28.08M | 21.28M |
| Gross Profit | 258.54M | 219.62M | 112.98M | 79.34M | 71.55M |
| SG&A Expenses | 247.26M | 212.48M | 186.38M | 154.76M | 147.55M |
| Depreciation & Amortization | 2.08M | 1.94M | 1.54M | 1.26M | 1.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 506.25M | 513.55M | 403.69M | 361.29M | 322.66M |
| Operating Income | -200.28M | -249.71M | -261.35M | -253.88M | -229.84M |
| Income Before Tax | -162.10M | -326.93M | -368.70M | -320.44M | -255.67M |
| Income Tax Expenses | 1.47M | 1.55M | 1.32M | 1.24M | 912.00K |
| Earnings from Continuing Operations | -163.56M | -328.49M | -370.02M | -321.69M | -256.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -163.56M | -328.49M | -370.02M | -321.69M | -256.58M |
| EBIT | -200.28M | -249.71M | -261.35M | -253.88M | -229.84M |
| EBITDA | -195.80M | -244.68M | -257.89M | -250.66M | -227.23M |
| EPS Basic | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 |
| Normalized Basic EPS | -0.61 | -0.75 | -0.78 | -0.86 | -0.82 |
| EPS Diluted | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 |
| Normalized Diluted EPS | -0.61 | -0.75 | -0.78 | -0.86 | -0.82 |
| Average Basic Shares Outstanding | 215.47M | 213.64M | 211.76M | 189.30M | 180.86M |
| Average Diluted Shares Outstanding | 215.47M | 213.64M | 211.76M | 189.30M | 180.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |